![Julio Font](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Font
Vorstandsvorsitzender bei Noray Bioinformatics SL
Aktive Positionen von Julio Font
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Vorstandsvorsitzender | 21.10.2002 | - |
Gründer | 21.10.2002 | - | |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Julio Font
Statistik
International
Spanien | 3 |
Operativ
Chief Executive Officer | 2 |
Founder | 1 |
Sektoral
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Technology Services |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Health Technology |
- Börse
- Insiders
- Julio Font
- Erfahrung